Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/s10434-008-0099-4
Annals of Surgical Oncology 15:3178-3186 (2008)
© 2008 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Falconi, M.
Right arrow Articles by Pederzoli, P.
PubMed
Right arrow Articles by Falconi, M.
Right arrow Articles by Pederzoli, P.

Original Article

Prognostic Relevance of Lymph Node Ratio and Number of Resected Nodes after Curative Resection of Ampulla of Vater Carcinoma

Massimo Falconi, MD1, Stefano Crippa, MD1, Ismael Domínguez, MD2, Giuliano Barugola, MD1, Paola Capelli, MD3, Stefano Marcucci, MD1, Stefania Beghelli, MD4, Aldo Scarpa, MD3, Claudio Bassi, MD1 and Paolo Pederzoli, MD1

1 Chirurgia Generale B (Pancreas Unit), Department of Surgery, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro, 37134 Verona, Italy
2 Department of Surgery (ID), Instituto Nacional de Ciencias Medicas y Nutricion "Salvador Zubiran", Mexico City, Mexico
3 Department of Pathology, University of Verona, Policlinico GB Rossi, Verona, Italy
4 IRCCS Istituto Oncologico Veneto, Padova, Italy

Correspondence: Address correspondence and reprint requests to: Massimo Falconi, MD; E-mail: massimo.falconi{at}univr.it

Background: Nodal metastasis is considered a major prognostic factor in patients with ampulla of Vater carcinoma (AVC). No study has investigated the significance of the ratio between metastatic and resected/examined lymph nodes (LNR) in patients with AVC.

Methods: Demographic, operative, and pathology data, including number of resected/evaluated nodes and LNR, were collected from patients who underwent pancreaticoduodenectomy with radical intent for invasive AVC from 1990 to 2005. Survival rates and recurrence patterns were evaluated and predictors were identified.

Results: In 90 evaluable patients (51 males, 39 females, median age 62.5 years), 5-year disease-specific survival (DSS) was 61%. The median number of resected/evaluated nodes was 16 (range: 5–47); 50% of the patients had nodal metastases. The 5-year DSS according to LNR was 75%, 49%, 38%, and 0% for LNR = 0, LNR>0 and ≤0.2, LNR>0.2, and ≤0.4, and LNR >0.4 (P = 0.002), respectively. The 5-year DSS was 81% in patients with >16 resected/evaluated nodes compared with 45% in those with ≤16 resected/evaluated nodes (P = 0.001). On multivariate analysis LNR and a number of resected/evaluated nodes >16 were significant predictors of survival; a number of resected/evaluated nodes>16 was also the only independent predictor of recurrence.

Conclusions: After curative resection for AVC, LNR and a cutoff of 16 resected/evaluated nodes are powerful prognostic factors. LNR might represent a major parameter for patient stratification in adjuvant treatment trials.

Key Words: Ampullary cancer • Lymph node ratio • Prognosis • Lymphadenectomy • Staging • Surgery







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society of Surgical Oncology.